Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745
Error in Table
Reference
- Van de Velde, M.E.; Kaspers, G.J.L.; Abbink, F.C.H.; Twisk, J.W.R.; van der Sluis, I.M.; van den Bos, C.; van den Heuvel-Eibrink, M.M.; Segers, H.; Chantrain, C.; van der Werff Ten Bosch, J.; et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745. [Google Scholar] [CrossRef] [PubMed]
One-Hour Administration Group (n = 45) | Push Administration Group (n = 45) | |
---|---|---|
Sex | ||
Male | 26 (58) | 24 (53) |
Female | 19 (42) | 21 (47) |
Age, years (mean(SD)) | 9.06 (5.11) | 9.29 (5.25) |
Age ≥ 5 years and included for ped-mTNS assessment | 32 (71) | 34 (76) |
Disease | ||
Acute lymphoblastic leukemia | 29 (64) | 29 (64) |
Hodgkin lymphoma | 7 (16) | 11 (24) |
Nephroblastoma | 6 (13) | 2 (4) |
Medulloblastoma | 1 (2) | 1 (2) |
Rhabdomyosarcoma | 2 (4) | 0 (0) |
Low-grade glioma | 0 (0) | 2 (4) |
Ancestry a | ||
Europe | 36 (80) | 37 (82) |
Eastern Asia | 1 (2) | 0 (0) |
Latin-America (including Caribbean) | 1 (2) | 2 (4) |
Middle-East (including Northern Africa) | 3 (7) | 3 (7) |
Sub-Saharan Africa | 1 (2) | 0 (0) |
Combination | 2 (4) | 3 (7) |
Missing | 1 (2) | 0 (0) |
No. (%) of patients needing VCR dose reductions or omissions | 1 (3) | 0 (0) |
No. (%) of patients using analgesics for neuropathic pain | 9 (20) | 11 (24) |
Relapse (No. (%)) | 2 (4) | 1 (2) |
Death (No. (%)) | 3 (7) | 1 (2) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
van de Velde, M.E.; Kaspers, G.J.L.; Abbink, F.C.H.; Twisk, J.W.R.; van der Sluis, I.M.; van den Bos, C.; van den Heuvel-Eibrink, M.M.; Segers, H.; Chantrain, C.; van der Werff ten Bosch, J.; et al. Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745. Cancers 2023, 15, 1359. https://doi.org/10.3390/cancers15051359
van de Velde ME, Kaspers GJL, Abbink FCH, Twisk JWR, van der Sluis IM, van den Bos C, van den Heuvel-Eibrink MM, Segers H, Chantrain C, van der Werff ten Bosch J, et al. Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745. Cancers. 2023; 15(5):1359. https://doi.org/10.3390/cancers15051359
Chicago/Turabian Stylevan de Velde, Mirjam Esther, Gertjan J. L. Kaspers, Floor C. H. Abbink, Jos W. R. Twisk, Inge M. van der Sluis, Cor van den Bos, Marry M. van den Heuvel-Eibrink, Heidi Segers, Christophe Chantrain, Jutte van der Werff ten Bosch, and et al. 2023. "Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745" Cancers 15, no. 5: 1359. https://doi.org/10.3390/cancers15051359